Stammdaten
Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Unternehmen & Branche
| Name | NIKA PHARMACEUTICALS, INC |
|---|---|
| Ticker | NIKA |
| CIK | 0001145604 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 421,1 Mio. USD |
| Beta | 0,12 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -76,398 | 0.00 | 20,996 | -297,628 | |
| 2025-09-30 | 10-Q | -7,999 | 0.00 | 23,625 | -260,539 | |
| 2025-06-30 | 10-Q | -18,381 | 0.00 | 31,607 | -252,557 | |
| 2025-03-31 | 10-Q | -12,945 | 0.00 | 34,988 | -234,176 | |
| 2024-12-31 | 10-K | 0 | -95,792 | 0.00 | 17,934 | -221,230 |
| 2024-09-30 | 10-Q | -8,367 | 0.00 | 1,386 | -200,411 | |
| 2024-06-30 | 10-Q | 156 | -22,457 | 0.00 | 390,322 | -208,778 |
| 2024-03-31 | 10-Q | -45,952 | 0.00 | 41,473 | -224,482 | |
| 2023-12-31 | 10-K | 0 | -64,833 | 0.00 | 19,596 | -82,149 |
| 2023-09-30 | 10-Q | 0 | -10,143 | 0.00 | 10,910 | -74,835 |
| 2023-06-30 | 10-Q | 0 | -10,143 | 0.00 | 11,053 | -64,692 |
| 2023-03-31 | 10-Q | 0 | -19,570 | 0.00 | 4,459 | -36,886 |
| 2022-12-31 | 10-K | 0 | -3,183,715 | 0.00 | 864 | -17,316 |
| 2022-09-30 | 10-Q | 0 | -6,339 | 0.00 | 3,914 | -2,266 |
| 2022-06-30 | 10-Q | 0 | -3,156,010 | 0.00 | 8,545 | 4,073 |
| 2022-03-31 | 10-Q | 0 | -6,316 | 0.00 | 83 | 83 |
| 2021-12-31 | 10-K | 0 | -14,712 | 0.00 | 399 | -23,619 |
| 2021-09-30 | 10-Q | 2,699 | 0.00 | 1,699 | -20,319 | |
| 2021-06-30 | 10-Q | 2,959 | 0.00 | 398 | -17,620 | |
| 2021-03-31 | 10-Q | 5,754 | 0.00 | 1,357 | -14,661 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.